Bipin Kulkarni

813 total citations
34 papers, 500 citations indexed

About

Bipin Kulkarni is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bipin Kulkarni has authored 34 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 9 papers in Genetics and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bipin Kulkarni's work include Platelet Disorders and Treatments (17 papers), Blood Coagulation and Thrombosis Mechanisms (13 papers) and Hemophilia Treatment and Research (10 papers). Bipin Kulkarni is often cited by papers focused on Platelet Disorders and Treatments (17 papers), Blood Coagulation and Thrombosis Mechanisms (13 papers) and Hemophilia Treatment and Research (10 papers). Bipin Kulkarni collaborates with scholars based in India, Antigua and Barbuda and Egypt. Bipin Kulkarni's co-authors include Shrimati Shetty, Kanjaksha Ghosh, Sona Nair, Dipika Mohanty, D. Mohanty, Kanjaksha Ghosh, Aruna Pawar, Patrícia R. Pinto, Cecil Ross and Kinjalka Ghosh and has published in prestigious journals such as PLoS ONE, European Journal of Pharmacology and British Journal of Haematology.

In The Last Decade

Bipin Kulkarni

33 papers receiving 483 citations

Peers

Countries citing papers authored by Bipin Kulkarni

Since Specialization

Citations

This map shows the geographic impact of Bipin Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bipin Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bipin Kulkarni more than expected).

Fields of papers citing papers by Bipin Kulkarni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bipin Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bipin Kulkarni. The network helps show where Bipin Kulkarni may publish in the future.

Co-authorship network of co-authors of Bipin Kulkarni

This figure shows the co-authorship network connecting the top 25 collaborators of Bipin Kulkarni. A scholar is included among the top collaborators of Bipin Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bipin Kulkarni. Bipin Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fibrosis and bone marrow: understanding causation and pathobiology 2023 ·Journal of Translational Medicine ·Kanjaksha Ghosh, Durjoy K. Shome, Bipin Kulkarni, Malay Ghosh, Kinjalka Ghosh	15
2	Efficacy of emicizumab in von Willebrand disease (VWD) patients with and without alloantibodies to von Willebrand factor (VWF): Report of two cases and review of literature 2022 ·Haemophilia ·Chandrakala Shanmukhaiah, Farah Jijina, (unknown), (unknown), Bipin Kulkarni, (unknown), Madiha Shaikh, Aditi Joshi, (unknown), Shashikant Apte	16
3	Rare Occurrence of Inhibitors in Von Willebrand Disease: A Case Report 2022 ·Frontiers in Medicine ·Bipin Kulkarni, (unknown), Chandrakala Shanmukhaiah, Shrimati Shetty	1
4	Dysfunctional fibrinolysis and cerebral venous thrombosis 2017 ·Blood Cells Molecules and Diseases ·(unknown), Shrimati Shetty, Kanjaksha Ghosh, Bipin Kulkarni	3
5	The Epidemiology of FVIII Inhibitors in Indian Haemophilia A Patients 2014 ·Indian Journal of Hematology and Blood Transfusion ·Patrícia R. Pinto, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bipin Kulkarni, Kanjaksha Ghosh, Shrimati Shetty	16
6	Molecular Pathology of Rare Bleeding Disorders (RBDs) in India: A Systematic Review 2014 ·PLoS ONE ·Bipin Kulkarni, Sona Nair, (unknown), (unknown), (unknown), (unknown), Shrimati Shetty, Kanjaksha Ghosh	9
7	A novel ELISA for diagnosis of Glanzmann’s thrombasthenia and the heterozygote carriers 2011 ·Annals of Hematology ·(unknown), Shrimati Shetty, Bipin Kulkarni, Kanjaksha Ghosh	3
8	Molecular pathology of haemophilia A in Indian patients: Identification of 11 novel mutations 2010 ·Clinica Chimica Acta ·(unknown), Shrimati Shetty, Bipin Kulkarni, Kanjaksha Ghosh	8
9	JAK2Mutations Across a Spectrum of Venous Thrombosis Cases: Table 1 2010 ·American Journal of Clinical Pathology ·Shrimati Shetty, Bipin Kulkarni, (unknown), (unknown), (unknown), Kanjaksha Ghosh	51
10	Antiphospholipid antibodies in haemophilia patients with severe bleeding tendency: cause, consequence or a consequential cause? 2009 ·Haemophilia ·Shrimati Shetty, (unknown), Bipin Kulkarni, (unknown), Kanjaksha Ghosh	3
11	Antiplatelet antibodies in cases of Glanzmann′s thrombasthenia with and without a history of multiple platelet transfusion 2009 ·Indian journal of human genetics ·Kanjaksha Ghosh, Bipin Kulkarni, Shrimati Shetty, Sona Nair	8
12	Utility of an exon 14 BslI polymorphism for improved genetic diagnosis of hemophilia A in Indian population 2008 ·Prenatal Diagnosis ·(unknown), Shrimati Shetty, Bipin Kulkarni, Kanjaksha Ghosh	1
13	Correlation of thromboelastographic patterns with clinical presentation and rationale for use of antifibrinolytics in severe haemophilia patients 2007 ·Haemophilia ·Kanjaksha Ghosh, Shrimati Shetty, Bipin Kulkarni	14
14	Contribution of natural anticoagulant and fibrinolytic factors in modulating the clinical severity of haemophilia patients 2007 ·British Journal of Haematology ·Shrimati Shetty, (unknown), Bipin Kulkarni, (unknown), (unknown), (unknown), Kanjaksha Ghosh	65
15	Frequency distribution of human platelet antigens in the Indian population 2005 ·Transfusion Medicine ·Bipin Kulkarni, D. Mohanty, Kanjaksha Ghosh	10
16	Platelet function tests using platelet aggregometry: need for repetition of the test for diagnosis of defective platelet function 2003 ·Platelets ·Kanjaksha Ghosh, Sona Nair, Bipin Kulkarni, (unknown), Shrimati Shetty, D. Mohanty	14
17	Spectrum of inherited bleeding disorders from Western India 2002 ·PubMed ·(unknown), Kanjaksha Ghosh, Shrimati Shetty, Sona Nair, (unknown), Bipin Kulkarni, Anil Pathare, (unknown), D. Mohanty	16
18	Human platelet alloantigen polymorphism in Glanzmann's thrombasthenia and its impact on the severity of the disease 2002 ·British Journal of Haematology ·Kanjaksha Ghosh, Bipin Kulkarni, Sona Nair, Shrimati Shetty, Dipika Mohanty	15
19	Glanzmann's thrombasthenia: updated 2002 ·Platelets ·Sona Nair, Kanjaksha Ghosh, Bipin Kulkarni, Shrimati Shetty, Dipika Mohanty	59
20	Development of inhibitors in patients with haemophilia from India 2001 ·Haemophilia ·Kanjaksha Ghosh, Shrimati Shetty, Bipin Kulkarni, Sona Nair, Aruna Pawar, (unknown), (unknown), D. Mohanty	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact